Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
Crossref DOI link: https://doi.org/10.1007/s00535-016-1184-2
Published Online: 2016-02-18
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamada, Takeshi
Yamamoto, Yoshiyuki
Moriwaki, Toshikazu
Hyodo, Ichisnosuke
Text and Data Mining valid from 2016-02-18